The elevated markers of hypercoagulability in children with Henoch-Schönlein purpura

Pediatric Hematology and Oncology

Volumn 22, Issue 1, 2005, Pages 41-48

  Yilmaz, Deniz ^a,b   Kavakli, Kaan ^a   Ozkayin, Nese ^a  

^a EGE UNIVERSITY   (Turkey)

^b Department of Pediatric Nephrology ^*  (Turkey)

Author keywords

Child; Henoch Sch nlein purpura; Hypercoagulability

Indexed keywords

ANTITHROMBIN; BIOCHEMICAL MARKER; D DIMER; FIBRINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; VON WILLEBRAND FACTOR;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ANAPHYLACTOID PURPURA; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; MALE;

ADOLESCENT; ANTITHROMBIN III; BIOLOGICAL MARKERS; BLOOD COAGULATION; CHILD; CHILD, PRESCHOOL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PROTHROMBIN; PURPURA, SCHOENLEIN-HENOCH; VON WILLEBRAND FACTOR;

EID: 11144231844     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010590896251     Document Type: Article

References (20)

1. Angelis CD, Feigin RD. Warshaw JB (eds.). Oski's Pediatric Principles and Practice, ed 3. Philadelphia: Lippincott Williams & Wilkins; 1999:2176-2179.
2. Tizard EJ. Henoch-Schonlein purpura. Arch Dis Child. 1999;80:380-383.
3. White RHR. Henoch-Schönlein purpura. In: Churg A, Churg J, eds. Systemic Vasculitides. New York: Igaku-Shoin; 1991:203-217.
4. White RHR, Yoshikawa N. Henoch Schonlein nephritis. In: Holliday MA, Barratt TM, Anver ED, Kogan BA, eds. Pediatric Nephrology, ed 3. Baltimore; MDs Williams & Wilkins; 1994:729-737.
5. Yalcindag A, Sundel R. Vasculitis in childhood. Curr Opin Rheumatol. 2001;13:422-427.
6. Kamitsuji H, Tani K, Yasui M, et al. Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch Schönlein purpura. Eur J Pediatr. 1987;146:519-523.
7. Culic S, Jakl R, Metlicic V, et al. Platelet function analysis in children with Schonlein-Henoch syndrome. Arch Med Res. 2001;32:268-272.
8. Boros G, Gofman L, Samsik J, Nagy J, Hamori A, Deak G. Blood coagulation abnormalities in the Schonlein-Henoch syndrome in adults. Acta Med Acad Sci Hung. 1979;36:151-166.
9. De Mattia D, Penza R, Giordano P, et al. von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura. Pediatr Nephrol. 1995;9:603-605.
10. Ates E, Bakkaloglu A, Saatci U, Soylemezoglu O. Von Willebrand factor antigen compared with other factors in vasculitic syndromes. Arch Dis Child. 1994;70:40-43.
11. Besbas N, Erbay A, Saatci U, et al. Thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor-1 in Henoch-Schonlein purpura. Clin Exp Rheumatol. 1998;16:95-98.
12. Brendel-Muller K, Hahn A, Schneppenheim R, Sanier R. Laboratory signs of activated coagulation are common in Henoch-Schönlein purpura. Pediatr Nephrol. 2001;16:1084-1088.
13. Claudy A. Coagulation and fibrinolysis in cutaneous vasculitis. Clin Dermatol. 1999;17:615-618.
14. Kiraz S, Ertemli I, Ozturk MA, Haznedaroglu IC, Çelik I, Çalgüneri M. Pathological haemostasis and 'prothrombotic state' in Behçet's disease. Thromb Res. 2002;105:125-133.
15. Calvino MC, Llorca J, Garcia-Porrua C, et al. Henoch-Schönlein purpura in children from north-western Spain: a 20 year epidemiologic and clinic study. Medicine. 2001;80:279-290.
16. Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arth Rheum. 1990;33:1114-1121.
17. Prandota J, Pankow-Prandota L, Kotecki L. Impaired activation of fibrinolytic system in children with Henoch-Schönlein purpura: beneficial effect of hydrocortisone plus aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis. Am J Ther. 2001;8:11-19.
18. Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP. Long term prognosis of Henoch-Schönlein nephritis in adults and children. Nephrol Dial Transplant. 1997;12:969-972.
19. Koskimies O, Mir S, Rapola J, Vilska J. Henoch-Schönlein nephritis: long term prognosis of unselected patients. Arch Dis Child. 1981;56:482-484.
20. Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch-Schonlein purpura. Eur J Pediatr. 2002;161:196-201.